Archive for September, 2011

Defense Witness In Second Hepatitis C Trial In Nevada, Dr. Arthur Reingold, Testimony on Plausible Cause for Contamination Impeached

...
READ THE FULL ARTICLE >>

Blueberry Consumption Reduces Growth and Spread of Breast Cancer Tumors in Mice

NEW YORK, Oct. 1, 2011 /PRNewswire/ -- In several studies recently conducted at the Beckman Research Institute at the City of Hope, Duarte, CA researchers found that feeding blueberry powder to mice significantly reduced the growth and spread of triple negative breast cancer cells, a...
READ THE FULL ARTICLE >>

Woman Calls 1-800-GET-THIN For Information, Loses 113 Pounds After Having The Lap-Band

LOS ANGELES, Sept. 30, 2011 /PRNewswire/ -- Elizabeth is now 36 years old, but she feels years younger. That's because she has gone from weighing 238 pounds to 125 pounds with the Lap-Band  procedure. That was after the five- foot six- inch Los Angeles woman realized that...
READ THE FULL ARTICLE >>

Sangamo BioSciences to Host Conference Call to Discuss Results From Phase 2b Trial of SB-509 in Diabetic Neuropathy

RICHMOND, Calif., Sept. 30, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will hold a teleconference and webcast at 8:30 am ET, on Monday, October 3, 2011, to discuss results of the Phase 2b clinical trial (SB-509-901) from its...
READ THE FULL ARTICLE >>

Synapse Biomedical obtient l’approbation de la FDA pour le système d’entrainement de diaphragme NeuRx (DPS)® pour traiter la sclérose latérale amyotrophique (SLA)

CLEVELAND, September 30, 2011 /PRNewswire/ -- Synapse Biomedical, Inc. a annoncé que la U.S. Food and Drug Administration (FDA) avait approuvé le Système d'entrainement de diaphragme NeuRx (DPS)® pour le traitement de la sclérose latérale...
READ THE FULL ARTICLE >>

Polyclinic Introduces Clinical Research Department With International HDL Study

SEATTLE, Sept. 30, 2011 /PRNewswire/ -- The Polyclinic is participating in a major international clinical research study aimed at raising HDL (good cholesterol) levels. As an entirely new department at The Polyclinic, clinical research opens up an additional arm of medicine for...
READ THE FULL ARTICLE >>

Synapse Biomedical erhält FDA-Zulassung für das NeuRx Diaphragm Pacing System (DPS)® bei der Behandlung von Amyotropher Lateralsklerose (ALS)

CLEVELAND, September 30, 2011 /PRNewswire/ -- Synapse Biomedical, Inc. gab heute bekannt, die US-Arzneimittelbehörde (FDA) habe das NeuRx Diaphragm Pacing System(DPS)® (Zwerchfellschrittmacher) für die Behandlung von Patienten mit Amyotropher Lateralsklerose...
READ THE FULL ARTICLE >>

Express Scripts Announces Single-Solution Approach to Pharma Services Through HealthBridge Pharma & Biotech

ST. LOUIS, Sept. 30, 2011 /PRNewswire/ -- Express Scripts has launched a suite of services for pharmaceutical and biotech companies through HealthBridge Pharma & Biotech, providing a single-solution approach to patient care.   HealthBridge Pharma & Biotech offers a full...
READ THE FULL ARTICLE >>

Expandable Prosthesis Resolves Advanced Aortic Valve Disease

CLEVELAND, Sep. 30, 2011 /PRNewswire/ -- Among individuals 65 years and older, as many as 30 percent have aortic valve sclerosis or stenosis and as a result of their deteriorating health, cannot enjoy a normal lifestyle. "The aortic valve is a gatekeeper," says Marco Costa, MD,...
READ THE FULL ARTICLE >>

Lifeline Biotechnologies and Depository Trust Company

RENO, Nev., Sept. 30, 2011 /PRNewswire/ -- Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that the Company continues efforts to reestablish DTC services. Jim Holmes, Lifeline's CEO said "While our efforts have continued to reestablish DTC's services to the Company...
READ THE FULL ARTICLE >>
« Older Entries
Get Adobe Flash playerPlugin by wpburn.com wordpress themes